Prevention & care

Shingles: reactivation, rash, nerve pain, transmission, treatment, and vaccination

7 sources · Latest source check 2026-10-08 UTC

On this page

Shingles is caused by reactivation of varicella-zoster virus, the same virus that causes chickenpox. The virus can remain in the body after the original infection and become active later. The usual result is a painful, often one-sided rash; shingles can occur more than once.[1]

Related labels describe different parts of the illness

Related labels describe different parts of the illness
Term	Meaning
Varicella or chickenpox	The initial infection caused by varicella-zoster virus.[1]
Herpes zoster or shingles	Reactivation of that virus later in the body.[1]
Dermatomal pattern	A rash in the area supplied by an affected nerve, commonly on one side.[5]
Postherpetic neuralgia	Nerve pain that persists in the affected area after the rash has cleared.[2]
Recombinant zoster vaccine	A vaccine intended to prevent shingles and related complications.[4]

Pain can precede the rash

Pain, itching or tingling can develop before visible blisters. The rash often forms a stripe on one side of the body or affects one side of the face. It can be more widespread, especially with weakened immunity. Fever, headache or feeling unwell may also occur.[2]

A rash affecting the eye or nose, a new vision change, pregnancy or a severely weakened immune system warrants prompt assessment under the NHS pathway. Local services differ. A familiar-looking rash is not enough to determine the seriousness or the appropriate treatment.[7]

A typical pattern and selected testing

Clinical appearance often guides assessment, but some cases are harder to recognize, particularly mild presentations in younger people. CDC describes PCR as a useful test for confirming VZV. Testing the cause of an atypical rash is different from deciding how urgent the illness is or what support is needed.[3]

CDC’s clinical-features page notes that shingles can be harder to establish without a rash and can resemble herpes simplex, contact dermatitis or other skin conditions. The usual one-sided nerve-area pattern is helpful context, not a complete photograph-based diagnosis.[5]

You do not catch shingles directly—but the virus can spread

A person with shingles can transmit VZV to someone who is susceptible to chickenpox. That person develops chickenpox rather than directly “catching shingles.” Contact with blister fluid and particles from blisters can spread the virus. Covering the rash and following infection-control advice helps protect others.[1][7]

CDC says shingles risk and complications increase with age and weakened immune function. A past episode does not guarantee protection from another. These are population risk contexts, not proof of one person’s trigger or a basis for predicting an exact future event.[1]

Antivirals and pain care have different purposes

CDC describes antivirals as reducing new lesions, viral shedding and acute pain, with greatest effectiveness when started early. This makes prompt assessment useful; it does not mean someone who presents later should assume assessment is pointless. The plan depends on the clinical situation.[3]

Care can also address pain, skin comfort and the effect on sleep or daily activity. NHS describes keeping the rash clean and dry, comfortable clothing and appropriate pain management. More severe or unusual symptoms and persistent pain need reassessment rather than one fixed recovery timetable.[7]

Healing skin and persistent nerve pain are different outcomes

Postherpetic neuralgia can last months or years after the rash has healed and can affect everyday life. Other complications include eye problems, secondary skin infection and, rarely, wider illness. Older adults and people with weakened immunity have greater complication risk, but not everyone develops prolonged pain.[2]

Prevention guidance needs a jurisdiction and population

CDC’s August 2025 US guidance recommends recombinant vaccine for adults aged 50 or older and adults aged 19 or older with weakened immune systems from disease or therapy. It also addresses people who previously had shingles. These US categories do not automatically describe eligibility or funding in every country.[4]

The vaccine is given as a series and is intended to prevent future disease. An acute episode, prior vaccination and immune status create timing or suitability questions. CDC’s guidance should be read in its stated scope; an article cannot select an individual vaccination plan.[4]

Evidence & uncertainty

Recognizing the rash, treating the acute episode, preventing future episodes and managing persistent nerve pain are different tasks. Early treatment matters, and eye involvement or a weakened immune system changes the urgency. Vaccination is prevention, not treatment of the current rash. Eligibility and access differ by country.[3][4]

Selected-source overview · Independent review pending

Published questions

Is shingles a new infection with a completely different virus from chickenpox?

Selected-source overview · Independent review pending. Read the evidence context.

Both involve varicella-zoster virus; shingles is reactivation after the original infection.[1]

Evidence behind this answer

About Shingles (Herpes Zoster)
agency condition explanation · 2025
Selected relevant official page passages inspected · Reactivation, repeat episodes, age/immunity context and VZV transmission